Winfield Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
AAMU
HJGA
Winfield Associates's QGEN Position: Q1 2018 in Review
Winfield Associates sold out of Qiagen (QGEN) in Q1 2018, closing a stake of 123 shares — an estimated $5K sold.
Winfield Associates first reported a position in QGEN in Q1 2017 and held it in 4 quarters. The position peaked at $5K in Q4 2017. 230 funds tracked by Wall St. Rank hold QGEN as of Q1 2018.
- Winfield Associates reported no remaining Qiagen position as of Q1 2018 after selling out during the quarter.
- Winfield Associates sold 123 Qiagen shares in Q1 2018, an estimated $5K.
- Winfield Associates first reported a position in Qiagen in Q1 2017 and held it in 4 quarters.
- Winfield Associates's Qiagen position peaked at $5K in Q4 2017.
- 230 funds tracked by Wall St. Rank held Qiagen as of Q1 2018.
Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.